Grand Rapids, Mich., June 13, 2024 — Sterile Processing Express (SPDx) announced today that it has achieved a major milestone in its healthcare business development. SPDx has received an Advanced Sterile Processing Certification from DNV GL, a global independent certification, assurance, and risk management provider. “Our team has diligently built a quality management system to provide the […]
Grand Rapids, MI., February 27, 2024 – Virtual Incision, a cultivate(MD) portfolio company, has been granted marketing authorization of the MIRA™ Surgical System (MIRA) from the FDA. This marks a significant milestone as MIRA becomes the first miniaturized robotic-assisted surgery device in the world approved for adult colectomy procedures. The device was submitted via the FDA’s De Novo
Physics-based STAGE™ quantitative output and ground truth data used with Canon AiCE (Advanced intelligent Clear-IQ Engine) deep learning reconstruction could significantly expand MRI access for neuroimaging BINGHAM FARMS, MI, and TUSTIN, CA, Jan. 16, 2024 – SpinTech MRI, creators of the STAGE™ (STrategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) software platform, and Canon Medical Systems
Grand Rapids, Mich., December 11, 2023 – cultivate(MD), a leader in medical device venture capital, is thrilled to announce that one of its portfolio companies, NSite Medical, has received FDA clearance for its groundbreaking AI-based scoliosis scanning application. This marks a significant milestone in advancing medical technology and offering new, innovative solutions for scoliosis management. NSite
cultivate(MD) Portfolio Company NSite Medical Announces FDA Clearance Read More »
Collaboration will assess operational and clinical impacts of STAGE through an analysis of neuroimaging efficiency, reporting workflows and clinical outcomes in actual cases. BINGHAM FARMS, MI, Nov. 27, 2023 – SpinTech MRI, creators of the STAGE™ (Strategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) software platform, today announced that Yale New Haven Hospital and
SpinTech MRI and Yale New Haven Hospital to Examine Impact of STAGE on MRI Read More »
Grand Rapids, Mich., November 27, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today that they have made a significant investment into Nanochon, a Washington, D.C.—based regenerative cartilage innovator. Nanochon develops solutions utilized by sports medicine physicians to treat active patients requiring
cultivate(MD) Capital Funds LP Announce Investment into Nanochon Read More »
